의료진

의료진소개

박정길 사진

박정길

  • [진료과] 소화기내과
  • [주연구분야] 비알코올지방간질환, 간암
  • [직위] 교수
  • [진료과목] 간염, 지방간질환, 알코올 간질환, 간경변증, 간암

진료예약

소화기내과 의료진의 진료과목, 오전과 오후의 예약가능 요일을 알려주며 예약관련 링크 제공
의사 진료과목 구분 예약
박정길 간염, 지방간질환, 알코올 간질환, 간경변증, 간암 오전 예약가능 예약가능 예약가능 전화 예약
(620-4030)
오후 예약가능

학력

2004년: 경북대학교 의과대학교 의학과 학사
2015년: 경북대학교 의과대학교 의학과 석사
2019년: 경북대학교 의과대학교 의학과 박사

경력

2014.~2016. 8.차의과학대학교 부속 구미차병원 조교수

학회 및 대외활동

학회 및 학술활동
대한간학회 정회원, 학술위원, 교육위원
대한임상초음파학회, 평생회원, 간행이사
대한간암학회 평생회원
대한소화기학회 평생회원
대한소화기내시경학회 평생회원
유럽간학회(EASL) 회원
아시안태평양간학회(APASL) 회원

발표 논문 (주저자)
1. Isolated Double-Chambered Right Ventricle in a Young Adult. The Korean Society of Cardiology 2001;41:272-275
2. Endoscopic Management of Rectal Dieulafoy’s lesion: A Case Series and Optimal Treatment. Clin Endosc. 2014;47(4):362-366.
3. Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy. World J Gastroenterol 2015;21(8):2568-2572
4. Severe fever with thrombocytopenia syndrome presenting as acute hepatic failure. Clin Exp Emerg Med 2015;2(2):1-4
5. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy. Clin Mol Hepatol 2015;21:242-248.
6. Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy. Clin Mol Hepatol 2015;21:287-294.
7. Successful Conservative Treatment of Spontaneous Perforated Duodenal Diverticulum: A Case Report. Korean J Helicobacter Up Gastrointest Res 2016;16:34-37.
8. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease A Korean nationwide, multicenter, retrospective, observational, cohort study Medicine. (Baltimore). 2017;96(24):e6580
9. Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years. Clin Radiol. 2017;72(8):692.e9-692.e15
10. Long‑term follow‑up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report. Oncol Lett. 2017;14:4853-4856
11. Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma: A STROBE-compliant article. Medicine (Baltimore). 2018;97(17):e0611.
12. Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B. Dig Liver Dis. 2018;50(6):628-630.
13. Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy. Med Princ Pract. 2018;27(2):197-200.
14. Tenofovir disoproxil fumarate-induced severe liver injury in a patient with chronic hepatitis B virus infection. Dig Liver Dis. 2018;50(6):628-630.
15. Simple Hepatic Cysts Mimicking Biliary Cystic Neoplasm after Ultrasound-Guided Percutaneous Alcohol Sclerotherapy. Clinical Ultrasound 2018; 3(2): 74-78.
16. Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease. Medicine (Baltimore) 2019;98(6):e14139).
17. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2019;34(9):1633-1640.
18. Anti-nuclear antibody-negative immunoglobulin G4-associated autoimmune hepatitis mimicking lymphoproliferative disorders. Yeungnam Univ J Med. 2020;37(2):136-140
19. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study. Nutrients. 2020;5;12(5):E1429.
20. of the Long Noncoding RNA GAS5 Correlates With Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Genes. 2020;13;11(5):E545.
21. Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Yonsei Med J. 2020;61(10):860-867.
22. Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis. Life (l). 2020;10(10):E230.
23. Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study. BMJ Open. 2020;10(11):e041989.
24. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2021;53(9):1030-1037.
25. Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease. Diagnostics (l). 2021;11(5):854.
26. Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver. Diagnostics (l). 2021;11(6):1061.
27. Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-d prospective cohort study. Diabetes Res Clin Pract. 2022;184:109208
28. Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19. Diagnostics (l). 2022;12(9):2255.
29. Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes. Endocrinol b (Seoul), In press
30. Impact of bolic factors on risk of cardiovascular disease in nondiabetic bolic dysfunction-associated fatty liver disease. Hepatol Int. Acceptance

수상경력

2017 The Liver Week, 우수 연제상 (Best Presentation Award)
2018 The Liver Week, 우수 연제상 (Best Presentation Award)

연수

2020.3~2021.2 University of California San Diego 방문교수 (Visiting scholar)

방송출연

질병백과

언론보도

YouTube 영상